Paul V. Effler

2.2k total citations
45 papers, 1.5k citations indexed

About

Paul V. Effler is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Paul V. Effler has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 15 papers in Infectious Diseases and 11 papers in Health. Recurrent topics in Paul V. Effler's work include Influenza Virus Research Studies (27 papers), Respiratory viral infections research (18 papers) and Pneumonia and Respiratory Infections (12 papers). Paul V. Effler is often cited by papers focused on Influenza Virus Research Studies (27 papers), Respiratory viral infections research (18 papers) and Pneumonia and Respiratory Infections (12 papers). Paul V. Effler collaborates with scholars based in Australia, United States and Philippines. Paul V. Effler's co-authors include Alan R. Katz, David M. Sasaki, Christopher C. Blyth, Peter Richmond, April K. Bogard, David W. Smith, Vernon Ansdell, Charles R. Middleton, Daniel B. Jernigan and Heath Kelly and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Paul V. Effler

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul V. Effler Australia	20	689	457	332	254	210	45	1.5k
Jennifer C. Moïsi United States	22	897 1.3×	369 0.8×	181 0.5×	138 0.5×	304 1.4×	89	1.6k
Tansy Edwards United Kingdom	26	528 0.8×	384 0.8×	206 0.6×	28 0.1×	419 2.0×	82	1.9k
Eric Lugada Uganda	14	851 1.2×	805 1.8×	99 0.3×	46 0.2×	49 0.2×	28	1.6k
A.M. Greenwood Gambia	22	241 0.3×	156 0.3×	291 0.9×	72 0.3×	116 0.6×	37	2.0k
Svein Gunnar Gundersen Norway	28	538 0.8×	623 1.4×	1.6k 4.9×	30 0.1×	55 0.3×	87	2.6k
Steve Black United States	20	1.4k 2.0×	335 0.7×	72 0.2×	321 1.3×	229 1.1×	27	1.9k
Ramesh Verma India	19	349 0.5×	140 0.3×	104 0.3×	109 0.4×	32 0.2×	105	1.1k
Beyene Moges Ethiopia	20	247 0.4×	304 0.7×	188 0.6×	31 0.1×	51 0.2×	37	1.0k
Lukas Fenner Switzerland	27	1.0k 1.5×	1.4k 3.0×	103 0.3×	65 0.3×	25 0.1×	88	2.0k
Farzin Davachi United States	19	478 0.7×	610 1.3×	98 0.3×	32 0.1×	25 0.1×	42	1.4k

Countries citing papers authored by Paul V. Effler

Since Specialization

Citations

This map shows the geographic impact of Paul V. Effler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul V. Effler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul V. Effler more than expected).

Fields of papers citing papers by Paul V. Effler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul V. Effler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul V. Effler. The network helps show where Paul V. Effler may publish in the future.

Co-authorship network of co-authors of Paul V. Effler

This figure shows the co-authorship network connecting the top 25 collaborators of Paul V. Effler. A scholar is included among the top collaborators of Paul V. Effler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul V. Effler. Paul V. Effler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carcione, Dale, et al.. (2025). Active Post-marketing Safety Surveillance of Nirsevimab Administered to Children in Western Australia, April–July 2024. The Pediatric Infectious Disease Journal. 44(5). e174–e176. 2 indexed citations

Wadia, Ushma, Hannah C. Moore, Peter Richmond, et al.. (2025). Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024. Journal of Infection. 90(4). 106466–106466. 10 indexed citations

Phillips, Anastasia, et al.. (2022). Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021. Internal Medicine Journal. 53(2). 275–279.

David, Annette M., Paul V. Effler, Yun‐Chul Hong, et al.. (2022). UHC—The critical platform towards a healthier and safer future in 2030 and beyond. The Lancet Regional Health - Western Pacific. 25. 100529–100529.

Gidding, Heather F., Heather F. Gidding, L.K. Flack, et al.. (2019). Infant, maternal and demographic predictors of delayed vaccination: A population-based cohort study. Vaccine. 38(38). 6057–6064. 18 indexed citations

Preen, David B., Peter Richmond, Peter Jacoby, et al.. (2018). The impact of influenza infection on young children, their family and the health care system. Influenza and Other Respiratory Viruses. 13(1). 18–27. 31 indexed citations

Moore, Hannah C., Parveen Fathima, Heather F. Gidding, et al.. (2018). Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study. Vaccine. 36(28). 4062–4069. 29 indexed citations

Rosewell, Alexander, et al.. (2016). Ebola outbreak in West Africa: considerations for strengthening Australia's international health emergency response. The Medical Journal of Australia. 204(7). 258–259.

Lim, Faye J., Avram Levy, Hannah C. Moore, et al.. (2016). Viral Etiology and the Impact of Codetection in Young Children Presenting With Influenza-Like Illness. Journal of the Pediatric Infectious Diseases Society. 6(3). piw042–piw042. 14 indexed citations

10.

Regan, Annette K., Christopher C. Blyth, Lauren Tracey, et al.. (2015). Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation. Vaccine. 33(31). 3689–3694. 20 indexed citations

11.

Blyth, Christopher C., Peter Richmond, Peter Jacoby, et al.. (2014). The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. Vaccine. 32(32). 4075–4081. 32 indexed citations

12.

Regan, Annette K., Christopher C. Blyth, Donna B Mak, Peter Richmond, & Paul V. Effler. (2014). Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Australian and New Zealand Journal of Obstetrics and Gynaecology. 54(6). 522–528. 17 indexed citations

13.

Armstrong, Paul, Gary K. Dowse, Paul V. Effler, et al.. (2011). Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open. 1(1). e000016–e000016. 98 indexed citations

14.

Blyth, Christopher C., et al.. (2011). Ensuring safety of the 2011 trivalent influenza vaccine in young children. The Medical Journal of Australia. 195(1). 52–52. 8 indexed citations

15.

Gold, Michael S., Paul V. Effler, Heath Kelly, Peter Richmond, & Jim Buttery. (2010). Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia. The Medical Journal of Australia. 193(10). 617–617. 2 indexed citations

16.

Imrie, Allison, et al.. (2008). Underrecognition of Leptospirosis During a Dengue Fever Outbreak in Hawaii, 2001–2002. Vector-Borne and Zoonotic Diseases. 8(4). 541–548. 51 indexed citations

17.

Wang, Susan A., et al.. (2004). Fluoroquinolone Resistance Among Neisseria gonorrhoeae Isolates in Hawaii, 1990–2000. Sexually Transmitted Diseases. 31(12). 702–708. 25 indexed citations

18.

Effler, Paul V., et al.. (2002). Evaluation of Eight Rapid Screening Tests for Acute Leptospirosis in Hawaii. Journal of Clinical Microbiology. 40(4). 1464–1469. 97 indexed citations

19.

Katz, Alan R., Vernon Ansdell, Paul V. Effler, Charles R. Middleton, & David M. Sasaki. (2001). Assessment of the Clinical Presentation and Treatment of 353 Cases of Laboratory‐Confirmed Leptospirosis in Hawaii, 1974–1998. Clinical Infectious Diseases. 33(11). 1834–1841. 168 indexed citations

20.

Effler, Paul V., et al.. (2001). The effect of a combined influenza/pneumococcal immunization reminder letter. American Journal of Preventive Medicine. 21(4). 256–260. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact